MBOAT2 and prostate carcinoma: The research also suggests that AR and ER transcriptionally upregulate the expression of MBOAT1 and MBOAT2, respectively, and inhibition of these receptors downregulates their transcriptional expression, sensitizing prostate cancer and breast cancer cells to ferroptosis.